· For research use only. Not for human consumption.
For research use only. Not for human consumption.
The natural vs synthetic peptides question comes up the moment anyone starts exploring research compounds. Some peptides exist naturally in the body. Others were designed from scratch in a laboratory. And a few blur the line entirely — built on a natural template but modified to behave differently. Understanding which category a compound falls into changes how you think about its research applications.
Natural peptides are molecules the body already makes. MOTS-c, for example, is encoded in mitochondrial DNA and was first identified by Lee et al. (2015) in Cell Metabolism (PMID: 25738459). Synthetic peptides like SS-31 were invented by scientists to target specific biological structures. Then there are hybrids like Selank, which started as a natural immune fragment and was modified for research purposes.
This guide explains the natural vs synthetic peptides distinction in plain language. For background on individual compounds mentioned here, see our guides on MOTS-c, SS-31, and Selank.
TL;DR: Natural peptides (MOTS-c, GHK-Cu, tuftsin) are produced by the body and discovered through biological research. Synthetic peptides (SS-31, BPC-157) are designed in laboratories for specific research purposes. Hybrid peptides (Selank, Semax) are based on natural fragments but structurally modified. All research-grade versions are manufactured through solid-phase peptide synthesis regardless of origin. For research use only. Not for human consumption.
What Are Natural vs Synthetic Peptides, Exactly?
A natural peptide is one the body produces on its own. It exists in your biology right now, doing something — sending signals, regulating processes, or serving some function scientists may not have fully mapped yet. When researchers “discover” a natural peptide, they are finding something that was already there.
A synthetic peptide is one that was designed and built by humans. It does not exist in nature. Scientists chose specific amino acids in a specific order to create a molecule with particular properties. The peptide only exists because someone decided to make it.
The distinction matters because it shapes what researchers can study. With a natural peptide, the core question is: “What is this molecule already doing in the body?” With a synthetic one, the question is: “What can this molecule we built do in a controlled setting?” Same scientific tools, different starting philosophy.
Natural Peptides: What the Body Already Makes
Some of the most studied research peptides were discovered inside the human body. They were not invented — they were found. Here are a few examples that show up regularly in the preclinical literature.
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome. Lee et al. (2015) identified it and documented its connection to metabolic signaling pathways in mouse models (PMID: 25738459). The body produces MOTS-c on its own — scientists simply discovered that it existed and started studying what it does.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human blood plasma, saliva, and urine. It was first isolated in the 1970s. Researchers noticed that young human plasma contained more of it than older plasma, which sparked decades of preclinical investigation.
Tuftsin is a four-amino-acid peptide produced by the spleen as part of the immune system. It was discovered in 1970 and has been studied for its role in activating certain immune cells. Tuftsin is also the parent molecule that Selank was built from.
What all natural peptides share is this: they were already part of biology before any scientist got involved. Research on them is essentially detective work — figuring out what these molecules do and why the body makes them.
Lee et al. (2015) identified MOTS-c as a 16-amino-acid peptide encoded by the 12S rRNA gene within the mitochondrial genome. The study, published in Cell Metabolism, demonstrated that this naturally occurring peptide functions as a mitochondrial signaling molecule with effects on metabolic regulation in mouse models. (PMID: 25738459)
Synthetic Peptides: Built From Scratch in the Lab
Synthetic peptides do not occur in nature. They are molecules that scientists designed with specific goals in mind. The amino acid sequence was chosen deliberately to interact with particular biological targets.
SS-31 is one of the clearest examples. It is a four-amino-acid synthetic peptide created by researchers Hazel Szeto and Peter Schiller. Mitchell et al. (2020) examined SS-31 in preclinical aging models and documented effects on mitochondrial function in aged mouse tissues (PMID: 32273339). The name “SS” literally stands for Szeto-Schiller — the scientists who built it. Nothing about this molecule exists naturally anywhere.
BPC-157 is an interesting case. It is called a “synthetic” peptide, but it was originally derived from a sequence found in human gastric juice proteins. The 15-amino-acid fragment does not exist as a standalone molecule in the body — scientists isolated the sequence and manufactured it independently. Gwyer et al. (2019) reviewed the preclinical literature on BPC-157 across multiple tissue models (PMID: 30915550).
The advantage of synthetic peptides is control. Scientists choose every amino acid. They can tweak the sequence, add modifications for stability, or design molecules to target structures that no natural peptide reaches. The disadvantage is that synthetic peptides lack the evolutionary track record of natural ones — there is no biological history to draw on.
Mitchell et al. (2020) investigated SS-31 (elamipretide) in aged mouse models, documenting effects on mitochondrial proteome and function. The study, published in eLife, examined this synthetic tetrapeptide’s interaction with the inner mitochondrial membrane in the context of age-related mitochondrial changes. (PMID: 32273339)
Hybrid Peptides: Natural Templates, Modified by Scientists
Some peptides do not fit neatly into either category. They started as natural fragments but were then altered by researchers. These hybrids combine a biological starting point with deliberate engineering.
Selank is the textbook example. It begins with tuftsin, a natural four-amino-acid immune peptide the body already produces. Russian researchers at the Institute of Molecular Genetics took that natural fragment and added a three-amino-acid tail (Pro-Gly-Pro) to make it last longer in biological environments. Kozlovskaya et al. (2003) studied Selank’s effects on anxiety-related behavior in animal models (PMID: 14969422). The result is a seven-amino-acid peptide that is part natural, part engineered.
Semax follows the same pattern. Its starting material is ACTH(4-7), a fragment of a naturally occurring brain hormone. Scientists added the same Pro-Gly-Pro tail for stability. Dolotov et al. (2006) documented Semax’s effects on neurotrophic factor expression in rat brain tissue (PMID: 16996037). Natural core, synthetic extension.
These hybrid peptides illustrate that the natural vs synthetic line is not always sharp. Biology provided the blueprint. Science provided the modifications. The result is something that would not exist without both contributions.
How Are All Research Peptides Actually Made?
Here is something that surprises many newcomers: regardless of whether a peptide is classified as natural, synthetic, or hybrid, the research-grade version you purchase from a supplier is always manufactured the same way. Nobody is extracting MOTS-c from actual mitochondria or harvesting tuftsin from spleens. Every research peptide is built through solid-phase peptide synthesis (SPPS).
SPPS works by attaching amino acids one at a time to a growing chain anchored to a solid surface (a tiny resin bead). Scientists add the amino acids in the exact order specified by the peptide’s sequence. Once the full chain is assembled, it is cut free from the bead, purified, and verified for identity and purity using HPLC and mass spectrometry.
This means a “natural” peptide like MOTS-c and a “synthetic” peptide like SS-31 both come off the same type of equipment. The difference is not in how they are made but in where the recipe originally came from — the body’s own genome, or a scientist’s design. For details on purity verification, see our HPLC guide and our Certificates of Analysis page.
Whether you are sourcing natural, synthetic, or hybrid peptides for your research, quality verification is the same across all categories. Alpha Peptides provides third-party HPLC purity data and mass spectrometry confirmation for every compound. Browse the full research catalog or review documentation on our COA page.
Frequently Asked Questions
Are natural peptides safer than synthetic ones?
The natural vs synthetic classification does not determine safety. Both categories contain molecules that are research chemicals sold for laboratory investigation only. A compound being found in the body does not automatically make it suitable for any application outside of controlled research. Safety profiles are determined through rigorous preclinical and clinical study, not by origin category.
Can synthetic peptides do things natural peptides cannot?
Yes, that is often the point of making them. Synthetic peptides can be designed to reach biological targets that no natural peptide accesses, to last longer in biological environments, or to interact with receptors in novel ways. SS-31, for example, was engineered specifically to reach cardiolipin on the inner mitochondrial membrane — no naturally occurring peptide does exactly that.
Why do researchers care whether a peptide is natural or synthetic?
The classification shapes the research questions. With natural peptides, scientists often study what the molecule does in the body normally and what happens when levels change. With synthetic peptides, the questions center on what a new compound can do when introduced into a controlled experimental system. Different origins lead to different experimental designs.
Are hybrid peptides more effective than pure natural or pure synthetic ones?
Effectiveness depends on the research question, not the classification. Selank’s Pro-Gly-Pro tail makes it last longer than bare tuftsin, which is useful for certain experimental designs. But that does not make it universally “better” — it makes it a different tool with different properties. Researchers choose compounds based on what they need for their specific study.
For research use only. Not for human consumption. This article is intended for informational purposes and does not constitute medical advice, dosing guidance, or therapeutic recommendations.
